Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy
Key facts
- Who runs it
- Azienda USL Reggio Emilia - IRCCS
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 17 people enrolled
- Started
- 29 Oct 2020
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- postural management
- Record updated
- 7 May 2026
Who can take part
- Age
- 1 year to 6 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Cerebral palsy spastic or dyskinetic
- GMFCS 4 or 5
- MP<41%
- Informed Consent acquired
Who cannot take part
- previous reconstructive hip surgery
- preventive surgery in previous 12 months
- muscle contracture overcoming defined passive Range Of Motion (ROM)limits
- anterior hip luxation
- lumbar scoliosis >20° Cobb
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Cerebral palsy (CP) is the most common motor disability in childhood. Among these, hip luxation represents the most frequent and clinically relevant one, affecting 72% of non-ambulatory CP children. Reconstructive surgical treatment is debated in severe CP children, for whom it is crucial to identify an effective preventive approach. The aim of our study is to verify if keeping a sitting position centering femoral heads is more effective than usual postural management (sitting with the trunk aligned and hips abducted), in preventing hip luxation in quadriplegic CP children. It's a multicenter randomized controlled study (13 sites involved). A total of 102 quadriplegic CP children, aged 1-6 years-old, classified as Gross Motor Function Measure System 4 or 5, will be recruited and randomized to usual or experimental sitting, at least 5 hours a day, for 2 years. The primary outcome will be the degree of luxation, measured by means of the Migration Percentage (MP), on pelvic radiography, at 12 and 24 months. Secondary outcomes will include compliance and Health Related-Quality of Life, using validated tools, hip pain, device cost, MRI lesions, concurrent direct neuromotor treatment, use of standing devices and spasticity treatments (botulinum toxin, per os or intrathecal baclofen, selective dorsal rhizotomy). Experimental sitting is expected to reduce the MP change compared to usual care. It will be of interest to compare compliance, QoL and costs in either groups: aspects affecting the effectiveness. Furthermore to evaluate correlations between MP and spasticity treatments, MRI lesion type, and other clinical features.
The 2 groups in the trial
- sitting position centering femoral headsTreatment being tested
sitting position centering femoral heads according to Lespargot diagram
Treatment: postural management
- Usual postural managementExisting treatment, for comparison
sitting with the trunk aligned and hips abducted to facilitate activities of daily living
Treatment: postural management
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Postural Management to Prevent Hip Luxation in Quadriplegic Cerebral Palsy Children: Comparing Two Approaches in a Randomized Controlled Trial
- Publications
- Record updated
- 7 May 2026